Search Within

Survivorship Research

Formats
  1. Journal Article (9016)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (367)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9330)
  2. Population Sciences Research Program (5762)
  3. Solid Tumor Oncology Division (5247)
  4. Surgery (5206)
  5. Epidemiology and Biostatistics (3671)
  6. Division of Subspecialty Medicine (3269)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (703)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (396)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (604)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1562)
  4. Wiley Blackwell (821)
  5. Oxford University Press (792)
  6. American Society of Hematology (791)

More Publishers

Results (15976)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The significance of mucin on rectal MRI in patients with locally advanced rectal cancer being considered for watch-and-wait after neoadjuvant therapy
    Meeting Abstract

    Judge, S.; Malekzadeh, P.; Corines, M. J.; Gollub, M. J.; Horvat, N.; Saltz, L. B.; Cercek, A.; Romesser, P. B.; Crane, C. H.; Wei, I. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy
    Meeting Abstract

    Romesser, P. B.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Alvarez, J.; Omer, D. M. R.; Sarkar, R.; Verheij, F. S.; Reyngold, M.; Wu, A. J. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • HER2 testing in the MOUNTAINEER trial: Analysis of treatment response based on central HER2 assessment using IHC/ISH and NGS
    Meeting Abstract

    Strickler, J. H.; Cercek, A.; Ng, K.; Siena, S.; Andre, T.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J. M.; Coveler, A. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers
    Meeting Abstract

    Balogun, F.; Altoe, M.; O'Connor, C.; Chowdhury, N.; Cercek, A.; Lee, C. K.; Foote, M. B.; Kim, D.; Maron, S. B.; Kim, D. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) to assess response in patients with anal cancer treated with definitive chemoradiation
    Meeting Abstract

    Alvarez, J.; Cercek, A.; Mohan, N.; Ho, Y. J.; Zinovoy, M.; Reyngold, M.; Yaeger, R.; Hajj, C.; Fanta, C.; Roth O'Brien, D. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
    Meeting Abstract

    Gu, S.; Dusza, S. W.; Dunkel, I. J.; Drilon, A. E.; Lacouture, M. E.; Markova, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save